Syringe Filtering with 0.22 Micron Filters: When, Why & How
A complete guide to 0.22 micron syringe filtration for peptide solutions — filter membrane types, sterilizing-grade vs particulate, peptide binding loss, and step-by-step procedure.
Syringe filtration through a 0.22 micron (0.2 μm) membrane is the standard method for sterilizing pharmaceutical solutions that cannot be autoclaved — including reconstituted peptides. This pore size removes bacteria (typically 0.4–1.0 μm) and most particulate matter while allowing peptide molecules (nanometers in size) to pass through. Done correctly, it produces a sterile filtrate. Done incorrectly or with the wrong membrane, it produces a peptide-depleted solution.
When and Why to Filter
Filtration is appropriate when: (1) reconstituting a peptide outside a cleanroom or laminar-flow hood, where airborne contamination risk is higher; (2) a vial has been punctured multiple times and bacterial sterility cannot be guaranteed; (3) the source peptide or BAC water has unknown sterility; (4) the filtration step replaces or supplements a cleanroom reconstitution protocol. Filtration is NOT appropriate as a substitute for proper aseptic technique — it removes bacteria from the final solution but does not remove endotoxins (lipopolysaccharides from gram-negative bacteria that pass through 0.22 μm filters).
Membrane Types: PES, PVDF, and Nylon
Polyethersulfone (PES): Low protein binding, hydrophilic, and compatible with aqueous peptide solutions. This is the preferred membrane for most research peptides. Minimal peptide loss per unit area. Good flow rate.
Polyvinylidene fluoride (PVDF): Also low protein binding and suitable for aqueous solutions. Slightly more hydrophobic than PES but adequate for most peptides when pre-wetted. Common in pharmaceutical manufacturing for sterilizing filtration.
Nylon: Higher protein binding than PES or PVDF. Can adsorb meaningful quantities of peptide to the membrane matrix, reducing yield and concentration. Generally not recommended for peptide filtration unless PES or PVDF is unavailable. Nylon also has limited compatibility with some organic solvents.
Peptide Loss to Filter Binding
All filter membranes adsorb some quantity of peptide, particularly on the first pass. This is called the hold-up volume or dead volume. For a 4 mm diameter syringe filter, dead volume is typically 10–50 μL. More significantly, surface adsorption to the membrane can retain peptide molecules, reducing the concentration of the filtrate. To minimize loss: (1) pre-saturate the filter by passing 0.2–0.5 mL of your reconstituted peptide through and discarding it, then filter the remainder; (2) use PES membranes; (3) add a carrier protein (e.g., albumin) if working with very dilute solutions, though this complicates later use.
Sterilizing-Grade vs. Particulate Filters
A sterilizing-grade filter meets the FDA’s definition: complete retention of Brevundimonas diminuta (ATCC 19146) at a challenge level of ≥1 × 10⁷ organisms/cm², as defined in FDA guidance for sterile drug products. Standard 0.22 μm syringe filters for laboratory use may not be certified to this standard. For research purposes, a laboratory-grade 0.22 μm PES filter is a reasonable risk-reduction step; for pharmaceutical-grade sterile preparation, only validated sterilizing-grade filters used in a controlled environment qualify.
Step-by-Step Filtration Procedure
1. Wipe the work surface with 70% isopropyl alcohol and allow to dry. 2. Gather: reconstituted peptide in vial, 0.22 μm PES syringe filter (sterile, individually packaged), sterile receiving vial or syringe, 3 mL or 5 mL luer-lock syringe. 3. Draw the peptide solution into the syringe (include 10–20% extra volume for dead volume loss). 4. Attach the syringe filter to the syringe. Do not touch the filter inlet or outlet with bare hands. 5. If pre-saturating: gently push 0.2–0.3 mL through into a waste container and discard. 6. Filter the remaining volume into the receiving vial by applying steady, gentle pressure. Do not force rapidly — excessive pressure can damage the membrane. 7. Cap the receiving vial immediately. Label with peptide, concentration (note the pre-saturation volume was discarded — adjust concentration calculation if needed), date, and expiry.
Endotoxin: What Filtration Cannot Do
Endotoxins (bacterial lipopolysaccharides) are approximately 1–50 nm in size — far below the 0.22 μm pore cutoff. They pass freely through all standard syringe filters. Endotoxin contamination in injected peptides can cause pyrogenic reactions (fever, chills, hypotension). The only reliable way to ensure low endotoxin levels is to source peptides from vendors who perform LAL (Limulus Amebocyte Lysate) testing and report endotoxin values on the COA. See /guides/reading-a-coa for COA evaluation guidance.
- Does filtering a peptide solution change its concentration?
- Yes, slightly. The filter membrane retains some peptide (dead-volume and surface adsorption). The effect is greatest for very dilute solutions and smallest for concentrated ones. Pre-saturating the filter by discarding the first 0.2–0.3 mL reduces this effect. For precise dosing applications, verify final concentration with UV absorbance or HPLC after filtration.
- Can I reuse a syringe filter?
- No. Syringe filters are single-use. Reusing a filter introduces contamination risk, membrane integrity uncertainty, and potential cross-contamination between peptides.
- What is the difference between 0.22 μm and 0.45 μm filters?
- 0.22 μm filters remove bacteria and are classified as sterilizing-grade when validated. 0.45 μm filters are particulate filters that remove fungi, protozoa, and large particles but do NOT reliably remove bacteria. For sterility, always use 0.22 μm.
- Is filtering necessary if I’m using a peptide from a reputable vendor?
- Not necessarily for every use case. Reputable vendors supplying lyophilized peptide in sterile, sealed vials with aseptic fill processes have already produced a sterile product. If you reconstitute with sterile BAC water using proper aseptic technique (swabbing stoppers, not touching needles), the risk is low. Filtration adds a safety margin, particularly for users reconstituting in non-controlled environments.
- FDA Guidance — Sterile Drug Products Produced by Aseptic Processing, 2004.. https://www.fda.gov/media/71026/download
- Adler M et al. (2012) — Analysis of adsorption of proteins to filters used in pharmaceutical manufacturing. PDA J Pharm Sci Technol.. https://pubmed.ncbi.nlm.nih.gov/22972741/